Plus news about Sanofi, Pharming, Skyhook Bio and Altay Therapeutics.
Ultragenyx Pharmaceutical sells second PRV this month: The commercial-stage rare disease drugmaker sold its second …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.